Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway.
Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway.
复制标题
DOI:
10.1016/j.celrep.2021.109547
复制
发表时间:
2021-08-17
期刊:
影响因子:
8.8
通讯作者:
Kapitsinou PP
中科院分区:
文献类型:
--
作者:
Torosyan R;Huang S;Bommi PV;Tiwari R;An SY;Schonfeld M;Rajendran G;Kavanaugh MA;Gibbs B;Truax AD;Bohney S;Calcutt MW;Kerr EW;Leonardi R;Gao P;Chandel NS;Kapitsinou PP
Prolonged cellular hypoxia leads to energetic failure and death. However, sublethal hypoxia can trigger an adaptive response called hypoxic preconditioning. While prolyl-hydroxylase (PHD) enzymes and hypoxia-inducible factors (HIFs) have been identified as key elements of oxygen-sensing machinery, the mechanisms by which hypoxic preconditioning protects against insults remain unclear. Here, we perform serum metabolomic profiling to assess alterations induced by two potent cytoprotective approaches, hypoxic preconditioning and pharmacologic PHD inhibition. We discover that both approaches increase serum kynurenine levels and enhance kynurenine biotransformation, leading to preservation of NAD+ in the post-ischemic kidney. Furthermore, we show that indoleamine 2,3-dioxygenase 1 (Ido1) deficiency abolishes the systemic increase of kynurenine and the subsequent renoprotection generated by hypoxic preconditioning and PHD inhibition. Importantly, exogenous administration of kynurenine restores the hypoxic preconditioning in the context of Ido1 deficiency. Collectively, our findings demonstrate a critical role of the IDO1-kynurenine axis in mediating hypoxic preconditioning. Torosyan et al. show that two potent cytoprotective strategies, hypoxic preconditioning and PHD inhibition, enhance kidney tissue resilience against ischemic injury by activating the kynurenine metabolic pathway. Specifically, they promote systemic kynurenine increase and enhance kynurenine metabolism, leading to preservation of NAD+ and generation of kynurenic acid in the post-ischemic kidney.
登录
查看更多内容
DOI:
10.4049/jimmunol.1500277
发表时间:
2015-06-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Chaudhary K;Shinde R;Liu H;Gnana-Prakasam JP;Veeranan-Karmegam R;Huang L;Ravishankar B;Bradley J;Kvirkvelia N;McMenamin M;Xiao W;Kleven D;Mellor AL;Madaio MP;McGaha TL
通讯作者:
McGaha TL
DOI:
10.1177/1178646920978236
发表时间:
2020
期刊:
International journal of tryptophan research : IJTR
影响因子:
--
作者:
Kartika R;Wibowo H;Purnamasari D;Pradipta S;Larasati RA
通讯作者:
Larasati RA
影响因子:
13.6
作者:
Hill, Peter;Shukla, Deepa;Maxwell, Patrick H.
通讯作者:
Maxwell, Patrick H.
影响因子:
13.6
作者:
Bernhardt, Wanja M.;Campean, Valentina;Eckardt, Kai-Uwe
通讯作者:
Eckardt, Kai-Uwe
DOI:
10.1073/pnas.1517820112
发表时间:
2015-10-20
影响因子:
11.1
作者:
Cole, Jennifer E.;Astola, Nagore;Monaco, Claudia
通讯作者:
Monaco, Claudia